Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Neos Therapeutics (NEOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2016	09-2016	06-2016	03-2016	12-2015
Assets
Current Assets
Cash & Cash Equivalents	24,352	43,489	41,886	42,392	90,763
Marketable Securities	15,430	16,547	38,232	33,730	N/A
Receivables	6,135	4,263	5,659	6,669	3,903
Inventories	5,767	5,683	4,427	2,501	2,520
Other current assets	3,585	1,980	1,732	7,842	1,058
TOTAL	$55,269	$71,962	$91,936	$93,134	$98,244

Non-Current Assets
PPE Net	7,076	6,952	6,848	5,403	5,124
Intangibles	17,647	15,969	16,360	16,772	16,672
Other Non-Current Assets	150	2,552	2,564	2,545	2,470
TOTAL	$24,873	$25,473	$25,772	$24,720	$24,266

Total Assets	$80,142	$97,435	$117,708	$117,854	$122,510

Liabilities
Current Liabilities
Short Term Debt	4,921	3,188	1,745	2,336	7,973
Accounts payable and accrued liabilities	7,798	7,808	3,299	9,343	4,824
Accrued Expenses	5,264	7,860	9,189	6,205	3,141
TOTAL	$21,645	$21,414	$16,847	$17,884	$15,938

Non-Current Liabilities
Long Term Debt	58,599	58,524	58,576	31,786	26,271
Deferred Revenues	3,662	2,558	2,614	N/A	N/A
Other Non-Current Liabilities	272	355	257	210	214
TOTAL	$60,045	$60,123	$60,159	$33,527	$28,198

Total Liabilities	$81,690	$81,537	$77,006	$51,411	$44,136

Shareholders' Equity
Shares Outstanding, K	22,561	16,061	16,071	16,046	16,035
Common Shares	16	16	16	16	16
Retained earnings	-200,118	-181,745	-155,938	-129,399	-116,785
Other shareholders' equity	-233	-162	-133	-112	-171
TOTAL	$-1,548	$15,898	$40,702	$66,443	$78,374

Total Liabilities And Equity	$80,142	$97,435	$117,708	$117,854	$122,510